Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/449
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorTOLEDO, Rodrigo A.-
dc.contributor.authorSEKIYA, Tomoko-
dc.contributor.authorLONGUINI, Viviane C.-
dc.contributor.authorCOUTINHO, Flavia L.-
dc.contributor.authorLOURENCO JR., Delmar M.-
dc.contributor.authorTOLEDO, Sergio P. A.-
dc.date.accessioned2013-07-30T14:41:48Z-
dc.date.available2013-07-30T14:41:48Z-
dc.date.issued2012-
dc.identifier.citationCLINICS, v.67, suppl.1, p.3-6, 2012-
dc.identifier.issn1807-5932-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/449-
dc.description.abstractThe finished version of the human genome sequence was completed in 2003, and this event initiated a revolution in medical practice, which is usually referred to as the age of genomic or personalized medicine. Genomic medicine aims to be predictive, personalized, preventive, and also participative (4Ps). It offers a new approach to several pathological conditions, although its impact so far has been more evident in mendelian diseases. This article briefly reviews the potential advantages of this approach, and also some issues that may arise in the attempt to apply the accumulated knowledge from genomic medicine to clinical practice in emerging countries. The advantages of applying genomic medicine into clinical practice are obvious, enabling prediction, prevention, and early diagnosis and treatment of several genetic disorders. However, there are also some issues, such as those related to: (a) the need for approval of a law equivalent to the Genetic Information Nondiscrimination Act, which was approved in 2008 in the USA; (b) the need for private and public funding for genetics and genomics; (c) the need for development of innovative healthcare systems that may substantially cut costs (e.g. costs of periodic medical follow-up); (d) the need for new graduate and postgraduate curricula in which genomic medicine is emphasized; and (e) the need to adequately inform the population and possible consumers of genetic testing, with reference to the basic aspects of genomic medicine.-
dc.description.sponsorshipFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/11942, 2009/15386-6]-
dc.description.sponsorshipConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [401990/2010-9]-
dc.description.sponsorshipCoordenacao de aperfeicoamento de pessoal de nivel superior (Capes)-
dc.description.sponsorshipFundacao Faculdade de Medicina (FFM)-
dc.description.sponsorshipFaculdade de Medicina da Universidade de Sao Paulo (FMUSP)-
dc.language.isoeng-
dc.publisherHOSPITAL CLINICAS, UNIV SAO PAULO-
dc.relation.ispartofClinics-
dc.rightsopenAccess-
dc.subjectMultiple Endocrine Neoplasia-
dc.subjectRET-
dc.subjectMEN1-
dc.subjectMedical Genetics-
dc.subject.otherfamilial somatotropinoma-
dc.subject.othergermline mutations-
dc.subject.otherhealth-
dc.subject.otherpheochromocytoma-
dc.subject.othergenomics-
dc.subject.otherfuture-
dc.subject.othertype-1-
dc.subject.othergene-
dc.subject.otheraip-
dc.titleNarrowing the gap of personalized medicine in emerging countries: the case of multiple endocrine neoplasias in Brazil-
dc.typearticle-
dc.rights.holderCopyright HOSPITAL CLINICAS, UNIV SAO PAULO-
dc.identifier.doi10.6061/clinics/2012(Sup01)02-
dc.identifier.pmid22584698-
dc.subject.wosMedicine, General & Internal-
dc.type.categoryreview-
dc.type.versionpublishedVersion-
hcfmusp.description.beginpage3-
hcfmusp.description.endpage6-
hcfmusp.description.issuesuppl 1-
hcfmusp.description.volume67-
hcfmusp.origemWOS-
hcfmusp.origem.idWOS:000304082400002-
hcfmusp.origem.id2-s2.0-84863916949-
hcfmusp.origem.idSCIELO:S1807-59322012001300002-
hcfmusp.publisher.citySAO PAULO-
hcfmusp.publisher.countryBRAZIL-
hcfmusp.relation.referenceAuffray C, 2009, GENOME MED, V1, DOI 10.1186/gm2-
hcfmusp.relation.referenceBarreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X-
hcfmusp.relation.referenceCollins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626-
hcfmusp.relation.referenceCosta MHS, 2011, CLINICS, V66, P529, DOI 10.1590/S1807-59322011000400002-
hcfmusp.relation.referenceDaly AF, 2010, J CLIN ENDOCR METAB, V95, pE373, DOI 10.1210/jc.2009-2556-
hcfmusp.relation.referenceEng C, 2010, ANN NY ACAD SCI, V1214, P70, DOI 10.1111/j.1749-6632.2010.05789.x-
hcfmusp.relation.referenceFrank-Raue K, 2011, HUM MUTAT, V32, P51, DOI 10.1002/humu.21385-
hcfmusp.relation.referenceGuttmacher AE, 2010, NAT REV GENET, V11, P161, DOI 10.1038/nrg2735-
hcfmusp.relation.referenceLourenco DM, 2008, EUR J ENDOCRINOL, V159, P259, DOI 10.1530/EJE-08-0153-
hcfmusp.relation.referenceLourenco Delmar Muniz Jr, 2007, Clinics (Sao Paulo), V62, P465-
hcfmusp.relation.referencePaim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8-
hcfmusp.relation.referenceQin YJ, 2010, NAT GENET, V42, P229, DOI 10.1038/ng.533-
hcfmusp.relation.referenceSantos Marcelo A C G dos, 2007, Arq Bras Endocrinol Metabol, V51, P1468-
hcfmusp.relation.referenceSantos Marcelo A C G dos, 2006, Arq Bras Endocrinol Metabol, V50, P7-
hcfmusp.relation.referenceSchmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9-
hcfmusp.relation.referenceSeguin B, 2008, NAT REV GENET, V9, pS5, DOI 10.1038/nrg2442-
hcfmusp.relation.referenceSimpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003-
hcfmusp.relation.referenceToledo RA, 2007, CLIN ENDOCRINOL, V67, P377, DOI 10.1111/j.1365-2265.2007.02895.x-
hcfmusp.relation.referenceToledo RA, 2010, J CLIN ENDOCR METAB, V95, P1318, DOI 10.1210/jc.2009-1355-
hcfmusp.relation.referenceToledo RA, 2007, J CLIN ENDOCR METAB, V92, P1934, DOI 10.1210/jc.2006-2394-
hcfmusp.relation.referenceToledo RA, 2010, CLINICS, V65, P407, DOI 10.1590/S1807-59322010000400010-
hcfmusp.relation.referenceToledo Sergio Pereira de Almeida, 2006, Clinics (Sao Paulo), V61, P59-
hcfmusp.relation.referenceToledo SPA, 2009, CLINICS, V64, P699, DOI 10.1590/S1807-59322009000700015-
hcfmusp.relation.referenceVictora CG, 2011, LANCET, V377, P2042, DOI 10.1016/S0140-6736(11)60055-X-
hcfmusp.relation.referenceYao L, 2010, JAMA-J AM MED ASSOC, V304, P2611, DOI 10.1001/jama.2010.1830-
dc.description.indexMEDLINE-
hcfmusp.remissive.sponsorshipCAPES-
hcfmusp.remissive.sponsorshipCNPq-
hcfmusp.remissive.sponsorshipFAPESP-
hcfmusp.remissive.sponsorshipFFM-
hcfmusp.remissive.sponsorshipFMUSP-
hcfmusp.lim.ref2012-
hcfmusp.citation.scopus8-
hcfmusp.scopus.lastupdate2022-06-24-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCM
Departamento de Clínica Médica - FM/MCM

Artigos e Materiais de Revistas Científicas - HC/ICESP
Instituto do Câncer do Estado de São Paulo - HC/ICESP

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/25
LIM/25 - Laboratório de Endocrinologia Celular e Molecular


Files in This Item:
File Description SizeFormat 
art_TOLEDO_Narrowing_the_gap_of_personalized_medicine_in_emerging_2012.PDFpublishedVersion (English)109.71 kBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.